European Countries to Resume COVID Immunizations with AstraZeneca Vaccine

Many leading European countries, including German, Italy and France, announced that they would resume vaccinations using Oxford-AstraZeneca’s COVID-19 vaccines after the European Medicines Agency’s examinations for potential side effects revealed that the immunization shot is “safe and effective”.

The decision of nearly a dozen EU member states after EU and British regulators moved to reassure the public that the vaccine was “not associated” with a higher risk of blood clots, saying that its capacity to protect people from coronavirus-related death or hospitalization outweigh its chance of harmful effect.

Many public health workers and experts have been worried that the slow phase of the inoculation programs of the COVID-19 shots would put the population of the EU nations in a dangerous state, mostly at a time when cases are increasing rapidly in the entire continent.

“This is a safe and effective vaccine,” EMA director Emer Cooke said on Friday. “If it were me, I would be vaccinated tomorrow.”

EMA officials said in a press conference that the agency would continue looking into the unusual clotting and bleeding disorders that had been reported in the past, including further consultation with other health experts to determine how common clotting disorders are.

The agency also said that it would continue conducting “lab tests to see if there is anything particular about these patients who are experiencing blood clots.”

“The evidence we have is, at the moment, not sufficient to conclude with certainty whether these adverse events are indeed caused by the vaccine or not,” Dr. Sabine Straus, chair of the agency’s risk committee, said in the press briefing.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.